Healthcare (Medicaid)

This bill expands Vermont's Dr. Dynasaur program to cover all young adults under age 26 who live in Vermont and have incomes at or below 312% of the federal poverty level. It directly affects Vermont residents aged 18-26 who currently might not qualify for the program due to age or income limits. The key change amends eligibility rules to remove previous restrictions, making coverage available to all qualifying young adults regardless of prior enrollment status. The program, administered under federal Medicaid/SCHIP rules, will take effect on July 1, 2025.

This bill requires most health insurance plans and Vermont Medicaid to cover biomarker testing when supported by specific evidence, such as FDA approvals, drug labels, or nationally recognized clinical guidelines. It directly affects patients needing these tests (e.g., for cancer diagnosis or treatment) and insurers/Medicaid, mandating coverage for tests analyzing genes, proteins, or other biological markers in blood or tissue. Key provisions include limiting disruptions in care (e.g., avoiding repeated biopsies) and defining biomarker testing broadly to include advanced genetic sequencing. The requirement takes effect January 1, 2026, for new plans, with Medicaid coverage pending CMS approval.